Probiotec Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PBP.AX research report →
Price Chart
About the company
Established in 1996 and based in Laverton North, Australia, Probiotec Limited is involved in the creation, production, packaging, and distribution of pharmaceuticals, consumer healthcare products, and fast-moving consumer goods both domestically and internationally. The company delivers extensive contract manufacturing solutions, covering the production of various formats including solid dose tablets, capsules, liquids, creams, gels, ointments, suspensions, and powders, alongside services like tablet coating, blister packing, and spray manufacturing. Furthermore, Probiotec offers analytical and stability testing, assists with new product formulation and trials, conducts continuous research and development, and provides a wide array of packaging options for human and animal nutrition items.
- CEO
- Wesley Stringer CPA, LLB
- IPO
- 2006
- Employees
- 111
- HQ
- Laverton North, VIC, AU
Get TickerSpark's AI analysis on PBP.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $242.34M
- P/E
- 21.29
- PEG
- 0.21
- P/S
- 1.13
- P/B
- 2.78
- EV/EBITDA
- 8.93
- Div Yield
- 3.61%
- Gross Margin
- 28.78%
- Op Margin
- 9.69%
- Net Margin
- 5.15%
- ROE
- 13.26%
- ROIC
- 7.55%
Latest fiscal year · YoY change
- Revenue
- $214.03M+17.4%
- Gross Profit
- $61.61M+12.4%
- Op Income
- $20.73M
- Net Income
- $11.02M-19.6%
- EPS
- $0.14-17.6%
- OCF Growth
- -12.1%
- FCF Growth
- -44.2%
- 52W High
- $3.03
- 52W Low
- $2.13
- 50D MA
- $2.90
- 200D MA
- $2.72
- Beta
- 0.47
- RSI (14)
- 58
- Avg Volume
- 135.19K
No earnings-call transcripts are available for PBP.AX yet.
- Free Float
- 53.7%
- Shares Outstanding
- 81.32M
- Float Shares
- 43.64M
Our PBP.AX coverage
Recent articles, reports, and earnings notes.
No research on PBP.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PBP.AX report →